Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cipla
Merck
US Department of Justice
AstraZeneca
US Army
Cantor Fitzgerald
Healthtrust
Accenture
Fuji

Generated: August 22, 2017

DrugPatentWatch Database Preview

HYDROXYZINE PAMOATE Drug Profile

« Back to Dashboard

Which patents cover Hydroxyzine Pamoate, and when can generic versions of Hydroxyzine Pamoate launch?

Hydroxyzine Pamoate is a drug marketed by Watson Labs, Heritage Pharma, Sandoz, Superpharm, Par Pharm, Impax Labs Inc, Ivax Sub Teva Pharms, Barr, Vangard, and Duramed Pharms Barr. and is included in thirty-four NDAs.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.

Summary for Tradename: HYDROXYZINE PAMOATE

Patents:0
Applicants:10
NDAs:34
Suppliers / Packagers: see list35
Bulk Api Vendors: see list26
Clinical Trials: see list36
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDROXYZINE PAMOATE at DailyMed

Pharmacology for Tradename: HYDROXYZINE PAMOATE

Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr
HYDROXYZINE PAMOATE
hydroxyzine pamoate
CAPSULE;ORAL088595-001Feb 29, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Vangard
HYDROXYZINE PAMOATE
hydroxyzine pamoate
CAPSULE;ORAL088392-001Sep 19, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE PAMOATE
hydroxyzine pamoate
CAPSULE;ORAL086695-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
HYDROXYZINE PAMOATE
hydroxyzine pamoate
CAPSULE;ORAL088593-001Feb 29, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE PAMOATE
hydroxyzine pamoate
CAPSULE;ORAL086705-001Jul 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
QuintilesIMS
Chubb
Express Scripts
Colorcon
McKesson
Covington
Medtronic
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot